St. Jude Medical wants a recently published article retracted, calling it a "biased analysis." But Douglas Zipes, managing editor of the online journal that published the article, said that's "not going to happen."
Leadership
In a companywide message, G. Mike Mikan said that the work being performed to address the company's challenges "absolutely must continue" and assured workers that he and other senior leaders are creating a blueprint for growth.
An unnamed source close to the Richfield-based electronics retailer told the Star Tribune that the company is investigating multiple complaints that Brian Dunn-who abruptly resigned Tuesday-behaved inappropriately with a female subordinate; Best Buy hasn't confirmed the assertion but declined to challenge the newspaper's reporting, and the company has vowed to publicly release the findings of the investigation that's underway.
Blue Cross and Blue Shield of Minnesota has hired or promoted seven new leaders, but it is still in the process of selecting a new chief financial officer and chief medical officer.
Latest Articles
Blue Cross and Blue Shield of Minnesota has hired or promoted seven new leaders, but it is still in the process of selecting a new chief financial officer and chief medical officer.
Wells Fargo reportedly said that it believes the Edina law firm's allegations "have no merit," adding that, "We will vigorously defend, and expect to prevail."
Best Buy said there was "mutual agreement that it was time for new leadership to address the challenges that face the company."
St. Jude claims that a recently published article that analyzed deaths tied to defibrillator leads contains "substantial errors" and a "biased analysis."
On the Reputation Institute's list of "America's Most and Least Reputable Big Companies," the Golden Valley-based food manufacturer jumped 14 spots from its 2011 ranking and beat out Seattle-based Amazon, last year's top-ranked company.
According to Forbes, Willard Oberton is one of 10 public company CEOs in America who have delivered the highest returns to their companies' shareholders relative to their total compensation.
Jeffrey Graves succeeds William Murray, who became interim CEO after Laura Hamilton left in August as the company was being investigated for its export practices.
The lawsuit claimed that Medtronic did not disclose to shareholders the adverse effects of its Infuse product, illegally marketed the product for uses not approved by regulators, and did not disclose to shareholders how much of the company's revenue from Infuse came from these unapproved uses.
Jeffrey Jones II succeeds former CMO Michael Francis, who left in October to become president of J.C. Penney Company; his appointment concludes a "comprehensive search" that included both internal and external candidates.
How local printer Studio on Fire ended up chronicled by a German art-book publisher.
Women make up half the work force but less than one-fifth of its executives. What’s being done to
remove the glass ceiling once and for all.
The thorny process of passing on a family business.
Dean Thomas Mengler wrote to U.S. News & World Report to express concerns about its decision to unrank the school from its "Best Law Firms" list, saying that the move serves as "a disincentive for law schools to promptly report mistaken or erroneous data."
The court determined that Prometheus' blood test involved naturally occurring phenomena, and its patents are therefore invalid; the ruling is expected to have broad implications in the scientific community.
Chief Financial Officer Pamela Sedmak, Chief Medical Officer Gregory Gilmet, and Kathleen Mock, senior vice president of marketing and public and health affairs, have reportedly left the Eagan-based insurer.